tiprankstipranks
Advertisement
Advertisement

CTXR Stock Latest News

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
Weekend UpdatesCTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
3d ago
AMT
CTMX
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
PremiumThe Fly
Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders
3d ago
CTXR
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright
8d ago
CTXR
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
PremiumCompany Announcements
Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility
17d ago
8K
CTXR
Citius Expands LYMPHIR Access with First European Shipment
PremiumCompany Announcements
Citius Expands LYMPHIR Access with First European Shipment
26d ago
8K
CTXR
Citius Oncology announces initial shipment of LYMPHIR to Europe
PremiumThe FlyCitius Oncology announces initial shipment of LYMPHIR to Europe
26d ago
CTOR
CTXR
Citius Pharmaceuticals Raises $5 Million in Securities Offering
Premium
Company Announcements
Citius Pharmaceuticals Raises $5 Million in Securities Offering
1M ago
8K
CTXR
Citius Pharmaceuticals announces $5M registered direct offering priced ATM
Premium
The Fly
Citius Pharmaceuticals announces $5M registered direct offering priced ATM
1M ago
CTXR
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
PremiumCompany Announcements
Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
2M ago
8K
CTXR
Citius Oncology advances LYMPHIR launch and global expansion
PremiumCompany Announcements
Citius Oncology advances LYMPHIR launch and global expansion
2M ago
8K
CTXR
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
PremiumCompany Announcements
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
3M ago
8K
CTXR
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
PremiumCompany Announcements
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
3M ago
8K
CTXR
Citius Pharmaceuticals receives $3.8M through NJEDA program
PremiumThe FlyCitius Pharmaceuticals receives $3.8M through NJEDA program
3M ago
CTXR
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
Premium
Company Announcements
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
3M ago
8K
CTXR
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
Premium
The Fly
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
3M ago
CTOR
CTXR
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
PremiumThe Fly
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
3M ago
CTOR
CTXR
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
PremiumThe Fly
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
3M ago
CTOR
CTXR
Is CTXR a Buy, Before Earnings?
PremiumPre-Earnings
Is CTXR a Buy, Before Earnings?
4M ago
CTXR
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
PremiumThe Fly
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
6M ago
CTOR
CTXR
Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
PremiumCompany AnnouncementsCitius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
6M ago
8K
CTXR
Citius Oncology to advance launch of Lymphir with Verix AI integration
Premium
The Fly
Citius Oncology to advance launch of Lymphir with Verix AI integration
6M ago
CTOR
CTXR
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
Premium
Company Announcements
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
7M ago
8K
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >